Non-steroidal Anti-inflammatory Drugs Market

Non-steroidal Anti-inflammatory Drugs Market Size, Share, Growth Analysis, By Disease Indication(Arthritis, Migraine, Ophthalmic Diseases, Others), By Distribution Channel(Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Region(North America, Asia Pacific, Europe, Latin America) - Industry Forecast 2025-2032


Report ID: UCMIG35B2118 | Region: Global | Published Date: Upcoming |
Pages: 165 | Tables: 55 | Figures: 60

Non-steroidal Anti-inflammatory Drugs Market Insights

Market Overview:

In 2021, the non-steroidal anti-inflammatory drugs (NSAIDs) market exhibited a significant value of USD 19,551.34 million on a global scale. Forecasts suggest that this market will continue to thrive with a compound annual growth rate (CAGR) of 5.36% between 2022 and 2030. These medications, known for their anti-inflammatory properties, are widely used to alleviate pain and reduce inflammation in various conditions. The projected growth reflects the increasing demand for NSAIDs, driven by factors such as rising incidences of chronic diseases and an aging population worldwide.

Non-steroidal Anti-inflammatory Drugs Market, Forecast & Y-O-Y Growth Rate, 2020 - 2028
ForecastGrowthRate
To get more reports on the above market click here to
Get Free Sample

This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.

Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.

The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Health Care Supplies by segment aggregation, the contribution of the Health Care Supplies in Health Care Equipment & Services and vendor share.

To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The market for Non-steroidal Anti-inflammatory Drugs was estimated to be valued at US$ XX Mn in 2021.

The Non-steroidal Anti-inflammatory Drugs Market is estimated to grow at a CAGR of XX% by 2028.

The Non-steroidal Anti-inflammatory Drugs Market is segmented on the basis of Disease Indication, Distribution Channel, Region.

Based on region, the Non-steroidal Anti-inflammatory Drugs Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

The key players operating in the Non-steroidal Anti-inflammatory Drugs Market are , Pfizer Inc. , Bayer AG , GSK plc , Dr. Reddy’s Laboratories Ltd , Viatris Inc , Teva Pharmaceutical Industries Ltd. , Johnson And Johnson Services Inc. , Merck & Co. Inc..

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Non-steroidal Anti-inflammatory Drugs Market

Report ID: UCMIG35B2118

$5,300
BUY NOW GET FREE SAMPLE